1-6 of 6
osteoclasts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A role for IL-34 in osteolytic disease of multiple myeloma

Muhammad Baghdadi, Kozo Ishikawa, Sayaka Nakanishi, Tomoki Murata, Yui Umeyama, Takuto Kobayashi, Yosuke Kameda, Hiraku Endo, Haruka Wada, Bjarne Bogen, Satoshi Yamamoto, Keisuke Yamaguchi, Ikumi Kasahara, Hiroshi Iwasaki, Mutsumi Takahata, Makoto Ibata, Shuichiro Takahashi, Hideki Goto, Takanori Teshima, Ken-ichiro Seino
Journal: Blood Advances
Blood Adv (2019) 3 (4): 541–551.
https://doi.org/10.1182/bloodadvances.2018020008
Published: 2019
Includes: Supplemental data
Journal Articles

ASXL1 impairs osteoclast formation by epigenetic regulation of NFATc1

Nidhi Rohatgi, Wei Zou, Patrick L. Collins, Jonathan R. Brestoff, Timothy H. Chen, Yousef Abu-Amer, Steven L. Teitelbaum
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2467–2477.
https://doi.org/10.1182/bloodadvances.2018018309
Published: 2018
Includes: Supplemental data
Journal Articles

Hypoxia promotes IL-32 expression in myeloma cells, and high expression is associated with poor survival and bone loss

Muhammad Zahoor, Marita Westhrin, Kristin Roseth Aass, Siv Helen Moen, Kristine Misund, Katarzyna Maria Psonka-Antonczyk, Mariaserena Giliberto, Glenn Buene, Anders Sundan, Anders Waage, Anne-Marit Sponaas, Therese Standal
Journal: Blood Advances
Blood Adv (2017) 1 (27): 2656–2666.
https://doi.org/10.1182/bloodadvances.2017010801
Published: 2017
Includes: Supplemental data
Journal Articles

Osteomacs interact with megakaryocytes and osteoblasts to regulate murine hematopoietic stem cell function

Safa F. Mohamad, Linlin Xu, Joydeep Ghosh, Paul J. Childress, Irushi Abeysekera, Evan R. Himes, Hao Wu, Marta B. Alvarez, Korbin M. Davis, Alexandra Aguilar-Perez, Jung Min Hong, Angela Bruzzaniti, Melissa A. Kacena, Edward F. Srour
Journal: Blood Advances
Blood Adv (2017) 1 (26): 2520–2528.
https://doi.org/10.1182/bloodadvances.2017011304
Published: 2017
Includes: Supplemental data
Journal Articles

TAK1 inhibition subverts the osteoclastogenic action of TRAIL while potentiating its antimyeloma effects

Hirofumi Tenshin, Jumpei Teramachi, Asuka Oda, Ryota Amachi, Masahiro Hiasa, Ariunzaya Bat-Erdene, Keiichiro Watanabe, Masami Iwasa, Takeshi Harada, Shiro Fujii, Kumiko Kagawa, Kimiko Sogabe, Shingen Nakamura, Hirokazu Miki, Kiyoe Kurahashi, Sumiko Yoshida, Kenichi Aihara, Itsuro Endo, Eiji Tanaka, Toshio Matsumoto, Masahiro Abe
Journal: Blood Advances
Blood Adv (2017) 1 (24): 2124–2137.
https://doi.org/10.1182/bloodadvances.2017008813
Published: 2017
Includes: Supplemental data
Journal Articles

Macrophages and osteoclasts stem from a bipotent progenitor downstream of a macrophage/osteoclast/dendritic cell progenitor

Yanling Xiao, Jara Palomero, Joanna Grabowska, Liqin Wang, Iris de Rink, Luuk van Helvert, Jannie Borst
Journal: Blood Advances
Blood Adv (2017) 1 (23): 1993–2006.
https://doi.org/10.1182/bloodadvances.2017008540
Published: 2017
Includes: Supplemental data